BioTonix: Annual and Special Meeting of Shareholders
Published: Jun 08, 2010
BOUCHERVILLE, QUEBEC--(Marketwire - June 08, 2010) - Biotonix (2010) Inc. (TSX VENTURE: BTX) ("Biotonix"), a leader in postural health and fitness, announced today agenda details of its annual and special meeting of shareholders:
DATE: Wednesday, June 16, 2010 TIME: 10:00 am to noon EST PLACE: Sheraton Centre Montreal 1201 Rene-Levesque W., Montreal, H3B 2L7 Ballroom centreAGENDA
Brian Edwards, Chairman of the Board of Directors, will host the formal segment of the meeting. Louise St-Onge, CEO, will present the company as well as an overview of activities and the 2010-2012 outlook.
After this presentation, Dr. Sylvain Guimond, D.O., Ph.D., President, and Daniel Langevin, CPGA, Head Coach of AGP's sport-etudes program (Association des golfeurs professionnels du Quebec), University of Montreal's Carabins-Golf and Golf Performance Academy, will officially launch Biotonix's personalized postural assessment solution for golf. In addition, they will conduct a live GolfPrint™ evaluation and feature a testimonial from Mario Lemieux following the product's trial in Tremblant. The product's microsite, www.GolfPrint.ca, will be unveiled at that moment.
Biotonix (TSX VENTURE: BTX) offers innovative health solutions for posture correction and fitness using a web-based imaging software technology. Biotonix is currently developing novel orthotics for the back and foot, also geared specifically toward improving posture. For more information please visit www.biotonix.com.
BIOTONIX'S FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While Biotonix anticipates that subsequent events and developments may cause its views to change, Biotonix specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
514-840-0004 ext 229
Julie M. Thibodeau, B.Sc., MBA
VP, Corporate Communications and Investor Relations
514-840-0004 ext 223